ScholarIQanswers from OpenAlex & ORCID
Mike Sampson
ResearcherPublications, citations & collaboration network
Mike Sampson is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Mike Sampson have?
ScholarIQindexed works
Mike Sampson has 105 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Mike Sampson have?
ScholarIQcitation count
Mike Sampson has 4,911 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Mike Sampson?
ScholarIQh-index
Mike Sampson has an h-index of 34 in OpenAlex.
What is the i10-index of Mike Sampson?
ScholarIQi10-index
Mike Sampson has an i10-index of 62 in OpenAlex.
What is the ORCID of Mike Sampson?
ScholarIQorcid
The ORCID for Mike Sampson is on the source record.
What is the OpenAlex record for Mike Sampson?
ScholarIQopenalex
The OpenAlex for Mike Sampson is on the source record.
What are the most-cited papers on Mike Sampson?
ScholarIQmost cited works
Large-Scale Association Studies of Variants in Genes Encoding the Pancreatic β-Cell KATP Channel Subunits Kir6.2 (<i>KCNJ11</i>) and SUR1 (<i>ABCC8</i>) Confirm That the <i>KCNJ11</i> E23K Variant Is Associated With Type 2 Diabetes
Anna L. Gloyn, Michael N. Weedon, Katharine R. Owen, Martina Turner, Bridget Knight, G. A. Hitman, Mark Walker, J Lévy, Mike Sampson, Stephanie Halford, Mark I. McCarthy, Andrew T. Hattersley, Timothy M. Frayling
Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels
Peter Clarkson, David S. Celermajer, Ann E. Donald, Mike Sampson, Keld E. Sørensen, Mark Adams, Dennis K. Yue, D. J. Betteridge, John Deanfield
Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes
Mike Sampson, Mark S. Winterbone, J. C. Hughes, Nicoletta Dozio, David A. Hughes
Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes
John R. B. Perry, Michael N. Weedon, Claudia Langenberg, Anne Jackson, Valeriya Lyssenko, Thomas Sparsø, Guðmar Þorleifsson, Harald Grallert, Luigi Ferrucci, Marcello Maggio, Giuseppe Paolisso, Mark Walker, Colin N.A. Palmer, Felicity Payne, Elizabeth Young, Christian Herder, Narisu Narisu, Mario A. Morken, Lori L. Bonnycastle, Katharine R. Owen, Beverley M. Shields, Beatrice Knight, Amanda J. Bennett, Christopher J. Groves, Aimo Ruokonen, Marjo‐Riitta Järvelin, Ewan R. Pearson, Laura Pascoe, Ele Ferrannini, Stefan R. Bornstein, Heather M. Stringham, Laura J. Scott, Johanna Kuusisto, Peter M. Nilsson, Malin Neptin, Anette P. Gjesing, Charlotta Pisinger, Torsten Lauritzen, Annelli Sandbæk, Mike Sampson, MAGIC, Ele Zeggini, Cecilia M. Lindgren, Valgerður Steinthórsdóttir, Unnur Þorsteinsdóttir, Torben Hansen, Peter Schwarz, Thomas Illig, Markku Laakso, Kari Stefansson, Andrew D. Morris, Leif Groop, Oluf Pedersen, Michael Boehnke, Inês Barroso, Nicholas J. Wareham, Andrew T. Hattersley, Mark I. McCarthy, Timothy M. Frayling
Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women With Type 2 Diabetes
Peter J. Curtis, Mike Sampson, John F. Potter, Ketan Dhatariya, Paul A. Kroon, Aedín Cassidy